BackBioceres Crop Solutions Overview

Bioceres Crop Solutions Total Revenue

Latest total revenue for BIOX: $260M, below the Industrials sector average of $380B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Revenue

$38.20M
35.9% YoY

As of Mar 2026

Annual Revenue (TTM)

$263.71M
31.2% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading

Bioceres Crop Solutions (BIOX) FAQ

As of the most recent data (March 2026), BIOX shows a total revenue of $260M. That compares with $380M in the prior-year period — down 31.2% year over year. That is below the Industrials sector average of $380B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOX's total revenue is now $260M (was $380M) — a 31.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bioceres Crop Solutions is outperforming or lagging.

The Industrials sector average total revenue is about $380B. Bioceres Crop Solutions is at $260M, which is lower that average. That is roughly 99.9% below the sector mean. Use the comparison chart on this page to see how BIOX stacks up against individual peers as well.

Tracking BIOX's total revenue over time shows whether Bioceres Crop Solutions is scaling, shrinking, or reshaping that part of the business. The current reading is $260M That compares with $380M in the prior-year period — down 31.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has Bioceres Crop Solutions's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $260M) with ownership activity and broader fundamentals.